Cabotegravir: The First Long-Acting Injectable for HIV Preexposure Prophylaxis.

CAB-LA is the first long-acting injectable agent for HIV PrEP. It is more effective than oral TDF/FTC, is well-tolerated aside from ISRs, and has few clinically significant drug-drug interactions.